Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients [Phase 2]
This document reports a completed Phase II pilot study evaluating tolerability and potential efficacy of subcutaneously administered recombi…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients
This completed clinical study assessed the effect of sildenafil citrate on brain blood flow in patients with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis
The study investigates blood vessel formation in multiple sclerosis using MR perfusion imaging and hypercapnia. The trial status is reported…
-
CLINICAL_TRIALS trial_result · 2008-02-15Clinical Trial Update: Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis [Phase 4]
Phase 4 clinical trial evaluating the efficacy of Cesamet (nabilone) for treating pain in patients with multiple sclerosis; study status is …
-
CLINICAL_TRIALS trial_result · 2008-01-30Clinical Trial Update: Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy [Phase 4]
Phase 4 trial update assessing the safety of Avonex (interferon beta-1a) in multiple sclerosis patients who have neutralizing antibodies to …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-12-17Clinical Trial Update: Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation [Phase 2]
A Phase 2 study in multiple sclerosis evaluated fatigue using three MRI assessments and transcranial magnetic stimulation. The trial is list…
-
CLINICAL_TRIALS trial_result · 2007-08-08Clinical Trial Update: Promoting Physical Activity for Persons With Multiple Sclerosis [NA]
This clinical trial update indicates a study aimed at promoting physical activity for people with Multiple Sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2007-05-14Clinical Trial Update: Optimizing IFN Beta - 1B Dose [Phase 3]
A Phase 3 trial evaluating optimized dosing of interferon beta-1B for multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2007-04-04Clinical Trial Update: Cannabis for Spasticity in Multiple Sclerosis [Phase 1, Phase 2]
A clinical trial update indicates Phase 1/Phase 2 studies evaluating cannabis for spasticity in multiple sclerosis have been terminated.
-
CLINICAL_TRIALS trial_result · 2006-09-14Clinical Trial Update: The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis [Phase 4]
Phase 4 trial update on escitalopram for depression in multiple sclerosis has been terminated, with no further efficacy or safety results re…
-
CLINICAL_TRIALS trial_result · 2006-08-29Clinical Trial Update: TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis [Phase 3]
Phase 3 clinical trial update for T-Cell Vaccination (TCV-01-002) in probable multiple sclerosis; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Yoga: Effect on Attention in Aging & Multiple Sclerosis [Phase 2]
This update notes the completion of a Phase 2 trial evaluating the effect of yoga on attention in individuals with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Natural Antioxidants in the Treatment of Multiple Sclerosis [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating natural antioxidants for the treatment of multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2006-07-07Clinical Trial Update: Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate [NA]
This clinical trial update reports an evaluation of gait in multiple sclerosis patients treated with glatiramer acetate.
-
CLINICAL_TRIALS trial_result · 2006-06-23Clinical Trial Update: Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis [Phase 1, Phase 2]
This update summarizes the short-term effects of medicinal cannabis therapy on spasticity in people with multiple sclerosis from a Phase 1/2…
-
CLINICAL_TRIALS trial_result · 2006-06-20Clinical Trial Update: Measuring the Balance Improvement on Multiple Sclerosis Patients After a Short Training Period With an APOS (All Phase Of Step Cycle) Kit [Phase 2]
This Phase 2 clinical trial update investigates whether a short training period with an APOS kit improves balance in people with multiple sc…
-
CLINICAL_TRIALS trial_result · 2006-06-05Clinical Trial Update: Optic Neuritis Treatment Trial (ONTT) [Phase 3]
Clinical trial update for the Optic Neuritis Treatment Trial (ONTT), a Phase 3 NEI-sponsored study comparing high-dose intravenous methylpre…